Larvol Delta - Bacainn-Therapeutics-Reports-Positive-Topline-Results-from-Phase-1-Study-of-BT051-a-Novel-Therapeutic-Approach-to-Treat-Inflammatory-Diseases-Such-As-Ulcerative-Colitis

BT051 - Bacainn Therap

https://www.businesswire.com/news/home/20201202005610/en/Bacainn-Therapeutics-Reports-Positive-Topline-Results-from-Phase-1-Study-of-BT051-a-Novel-Therapeutic-Approach-to-Treat-Inflammatory-Diseases-Such-As-Ulcerative-Colitis

Dec 2, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev